PF-Atlas › Clinical Trials › NCT00729430
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Omega-3 Fatty Acids · Phase 3
Registry ID
NCT00729430
Phase
Phase 3
Status
Completed
Drug / intervention
Omega-3 Fatty Acids (Fish Oil Supplements)
Sponsor
Brigham and Women's Hospital
Start
2008-08
Enrollment
358
Locations
1
About this trial
Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00729430 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.